Companies: 10,795·Total market cap: $144.5T
Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTXNASDAQHealthcare● Active
$13.55
+$0.29(+2.19%)
Market Cap$258616370
P/E Ratio
52W High$14.97
52W Low$7.37
Overview

Elicio Therapeutics, Inc.(ELTX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ELTX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.03B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)($0.00B)($0.00B)($0.00B)$0.03B
Gross Margin %(computed)95.64%
Operating Expenses
R&D Expenses$0.02B$0.03B$0.02B$0.02B$0.05B
G&A Expenses$0.01B$0.01B$0.01B$0.00B$0.00B
Total Operating Expenses$0.04B$0.04B$0.03B$0.02B$0.07B
Operating Income($0.04B)($0.04B)($0.04B)($0.02B)($0.04B)
Operating Margin %(computed)-138.84%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.04B)($0.05B)($0.04B)($0.03B)($0.05B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.04B)($0.05B)($0.04B)($0.03B)($0.03B)
Net Margin %(computed)-93.25%
Per Share & EBITDA
EPS (Basic)$-2.58$-4.25$-6.96$-9.10$-19.32
Wtd Avg Shares0.02B0.01B0.01B0.00B0.00B
EBITDA($0.04B)($0.05B)($0.03B)($0.02B)($0.05B)
EBITDA Margin %(computed)-183.40%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Elicio Therapeutics, Inc.

关于Elicio Therapeutics, Inc.(ELTX)损益表

Elicio Therapeutics, Inc.(ELTX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ELTX实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.04B)(净利率—)。

常见问题

ELTX · 4 问

Elicio Therapeutics, Inc.(ELTX)2025财年营收为$0.00B,同比down—%。

ELTX revenueELTX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09